[4] Conditions that match a drugs FDA approval generally qualify, whether youre using these major GLP-1 brands or similar: Ozempic/Mounjaro: type 2 diabetes [5] Wegovy/Zepbound: obesity (BMI 30) [6] Wegovy/Zepbound: overweight with at least one weight-related condition (BMI 27 to under 30 plus hypertension, high cholesterol, sleep apnea, cardiovascular disease, or type 2 diabetes) [7] Zepbound: obstructive sleep apnea [8] Wegovy: metabolic-associated steatohepatitis (MASH) [9] Off-label conditions can count too when your clinician documents a real diagnosis such as prediabetes, binge eating disorder, or PCOS
Krishnan, A., Hadi, Y., Hutson, W
Mohn and Schubeler, 2009)
Heterophile antibodies rarely affect B12 assays, because most capture the vitamin with intrinsic factor instead of an antibody
GLP-1 medications were originally developed to treat type 2 diabetes, but they are now FDA-approved for weight management as well